These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38182103)

  • 21. Identification of Poly(ADP-Ribose) Polymerase Macrodomain Inhibitors Using an AlphaScreen Protocol.
    Ekblad T; Verheugd P; Lindgren AE; Nyman T; Elofsson M; Schüler H
    SLAS Discov; 2018 Apr; 23(4):353-362. PubMed ID: 29316839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of PARP14 inhibitors using novel methods for detecting auto-ribosylation.
    Yoneyama-Hirozane M; Matsumoto SI; Toyoda Y; Saikatendu KS; Zama Y; Yonemori K; Oonishi M; Ishii T; Kawamoto T
    Biochem Biophys Res Commun; 2017 May; 486(3):626-631. PubMed ID: 28315326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Poly(ADP-ribose) Polymerase 9 (PARP9) as a Potent Suppressor for
    Zhu Z; Weng S; Zheng F; Zhao Q; Xu Y; Wu J
    Phenomics; 2024 Apr; 4(2):158-170. PubMed ID: 38884060
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Pandi K; Angabo S; Makkawi H; Benyamini H; Elgavish S; Nussbaum G
    J Dent Res; 2024 Mar; 103(3):329-338. PubMed ID: 38344758
    [No Abstract]   [Full Text] [Related]  

  • 25. Combining Chemical Genetics with Proximity-Dependent Labeling Reveals Cellular Targets of Poly(ADP-ribose) Polymerase 14 (PARP14).
    Carter-O'Connell I; Vermehren-Schmaedick A; Jin H; Morgan RK; David LL; Cohen MS
    ACS Chem Biol; 2018 Oct; 13(10):2841-2848. PubMed ID: 30247868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mono-ADP-ribosylation by PARP10 and PARP14 in genome stability.
    Dhoonmoon A; Nicolae CM
    NAR Cancer; 2023 Mar; 5(1):zcad009. PubMed ID: 36814782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection.
    Zhang Y; Mao D; Roswit WT; Jin X; Patel AC; Patel DA; Agapov E; Wang Z; Tidwell RM; Atkinson JJ; Huang G; McCarthy R; Yu J; Yun NE; Paessler S; Lawson TG; Omattage NS; Brett TJ; Holtzman MJ
    Nat Immunol; 2015 Dec; 16(12):1215-27. PubMed ID: 26479788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DTX3L E3 ligase targets p53 for degradation at poly ADP-ribose polymerase-associated DNA damage sites.
    Yan Q; Ding J; Khan SJ; Lawton LN; Shipp MA
    iScience; 2023 Apr; 26(4):106444. PubMed ID: 37096048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can molecular mimicry explain the cytokine storm of SARS-CoV-2?: An in silico approach.
    Obando-Pereda G
    J Med Virol; 2021 Sep; 93(9):5350-5357. PubMed ID: 33913542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid evolution of PARP genes suggests a broad role for ADP-ribosylation in host-virus conflicts.
    Daugherty MD; Young JM; Kerns JA; Malik HS
    PLoS Genet; 2014; 10(5):e1004403. PubMed ID: 24875882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of Intracellular Auto-Modification Levels of ARTD10 Using Mono-ADP-Ribose-Specific Macrodomains 2 and 3 of Murine Artd8.
    Bütepage M; Krieg S; Eckei L; Li J; Rossetti G; Verheugd P; Lüscher B
    Methods Mol Biol; 2018; 1813():41-63. PubMed ID: 30097860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural insight into the interaction of ADP-ribose with the PARP WWE domains.
    He F; Tsuda K; Takahashi M; Kuwasako K; Terada T; Shirouzu M; Watanabe S; Kigawa T; Kobayashi N; Güntert P; Yokoyama S; Muto Y
    FEBS Lett; 2012 Nov; 586(21):3858-64. PubMed ID: 23010590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycolytic rate and lymphomagenesis depend on PARP14, an ADP ribosyltransferase of the B aggressive lymphoma (BAL) family.
    Cho SH; Ahn AK; Bhargava P; Lee CH; Eischen CM; McGuinness O; Boothby M
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15972-7. PubMed ID: 21911376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PARPs and ADP-Ribosylation in Chronic Inflammation: A Focus on Macrophages.
    Santinelli-Pestana DV; Aikawa E; Singh SA; Aikawa M
    Pathogens; 2023 Jul; 12(7):. PubMed ID: 37513811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma.
    Barbarulo A; Iansante V; Chaidos A; Naresh K; Rahemtulla A; Franzoso G; Karadimitris A; Haskard DO; Papa S; Bubici C
    Oncogene; 2013 Sep; 32(36):4231-42. PubMed ID: 23045269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-Transcriptional Regulation of PARP7 Protein Stability Is Controlled by Androgen Signaling.
    Kamata T; Yang CS; Melhuish TA; Frierson HF; Wotton D; Paschal BM
    Cells; 2021 Feb; 10(2):. PubMed ID: 33572475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression.
    Grunewald ME; Chen Y; Kuny C; Maejima T; Lease R; Ferraris D; Aikawa M; Sullivan CS; Perlman S; Fehr AR
    PLoS Pathog; 2019 May; 15(5):e1007756. PubMed ID: 31095648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel role for the mono-ADP-ribosyltransferase PARP14/ARTD8 in promoting homologous recombination and protecting against replication stress.
    Nicolae CM; Aho ER; Choe KN; Constantin D; Hu HJ; Lee D; Myung K; Moldovan GL
    Nucleic Acids Res; 2015 Mar; 43(6):3143-53. PubMed ID: 25753673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B cell-intrinsic and -extrinsic regulation of antibody responses by PARP14, an intracellular (ADP-ribosyl)transferase.
    Cho SH; Raybuck A; Wei M; Erickson J; Nam KT; Cox RG; Trochtenberg A; Thomas JW; Williams J; Boothby M
    J Immunol; 2013 Sep; 191(6):3169-78. PubMed ID: 23956424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted Degradation of PARP14 Using a Heterobifunctional Small Molecule.
    Wigle TJ; Ren Y; Molina JR; Blackwell DJ; Schenkel LB; Swinger KK; Kuplast-Barr K; Majer CR; Church WD; Lu AZ; Mo J; Abo R; Cheung A; Dorsey BW; Niepel M; Perl NR; Vasbinder MM; Keilhack H; Kuntz KW
    Chembiochem; 2021 Jun; 22(12):2107-2110. PubMed ID: 33838082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.